Windlas Biotech (BOM:543329) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech ROE % Adjusted to Book Value?

Windlas Biotech's ROE % for the quarter that ended in Dec. 2024 was 13.22%. Windlas Biotech's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Windlas Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Windlas Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Windlas Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech ROE % Adjusted to Book Value Chart

Windlas Biotech Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

11.06

9.15

5.76

Windlas Biotech Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	6.38	-	3.58	-

Competitive Comparison of Windlas Biotech's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Windlas Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Windlas Biotech's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Windlas Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Windlas Biotech's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Windlas Biotech ROE % Adjusted to Book Value Calculation

Windlas Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.66%	/	2.37
	=	5.76%

Windlas Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.22%	/	N/A
	=	N/A

Windlas Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Windlas Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (BOM:543329) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

WINDLAS:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines